Drug & intervention
azilsartan
RxCUI 1091643
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
12 shownAzilsartan in Patients With Diabetic Kidney Disease and HypertensionNCT05753696 · 2023-04-01
UNKNOWNA Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With HypertensionNCT02791438 · 2016-08-18
COMPLETEDA Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With HypertensionNCT02451150 · 2015-08-01
COMPLETEDA Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.NCT02400775 · 2015-03-01
WITHDRAWNEfficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential HypertensionNCT02407210 · 2015-01-01
UNKNOWNA Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RNCT02079805 · 2014-06-01
COMPLETEDAzilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "NCT02100319 · 2014-03-03
COMPLETEDAzilsartan Circadian and Sleep PressureNCT01762501 · 2012-12-01
COMPLETEDAzilsartan Tablets Special Drug Use Surveillance: Long-term UseNCT02092025 · 2012-06-20
COMPLETEDNew Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure LoweringNCT01609959 · 2012-06-01
COMPLETEDEfficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionNCT01289132 · 2007-07-01
COMPLETEDEfficacy and Safety of Azilsartan in Subjects With Essential HypertensionNCT00759551 · 2004-08-01
COMPLETEDConditions being studied
Research locations
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.